...
首页> 外文期刊>Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association >Oncological feasibility of laparoscopic subtotal gastrectomy compared with laparoscopic proximal or total gastrectomy for cT1N0M0 gastric cancer in the upper gastric body
【24h】

Oncological feasibility of laparoscopic subtotal gastrectomy compared with laparoscopic proximal or total gastrectomy for cT1N0M0 gastric cancer in the upper gastric body

机译:腹腔镜椎间盘切除术的肿瘤学可行性与上胃体中CT1N0M0胃癌的腹腔镜近端或总胃切除术相比

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background The upper gastric body is of particular interest in relation to gastrectomy because this area includes a border; that is, both distal and proximal gastrectomy for early gastric cancer can involve this area. Laparoscopic subtotal gastrectomy (LsTG) is reported to be suitable procedure compared with laparoscopic proximal and total gastrectomy (LPG, LTG), regarding postoperative nutritional status and surgical safety. However, whether LsTG is an oncologically acceptable procedure for early gastric cancer in the upper gastric body is unclear. Methods We analyzed 215 patients with cT1N0M0 gastric cancer limitedly located in the upper gastric body. The frequency of conversion from each intended procedure to an alternative procedure, the width of the pathological margin, the incidence of lymph node metastasis at each station and the 3-year overall survival (OS) and relapse-free survival (RFS) were evaluated. Results LsTG was planned for 65 patients, and LPG for 72 and LTG for 78, respectively. Conversion to other procedures was required in about 10% of patients for whom LsTG or LPG was planned. The width of the pathological margin in patients who underwent LsTG was significantly shorter than patients who underwent the others. No patients who underwent LsTG, LPG or LTG had metastases in station no. 2 or 4sa lymph node. The 3-year OS and RFS rates of patients for whom each procedure was planned were not different. Conclusions LsTG could be an oncologically acceptable procedure for cT1N0M0 gastric cancer in the upper gastric body. LsTG could be one option for such disease.
机译:背景技术上胃体与胃切除术特别感兴趣,因为该区域包括边界;也就是说,对早期胃癌的远端和近端胃切除术可以涉及该地区。据报道,与腹腔镜近端和总胃切除术(LPG,LTG)相比,腹腔镜椎骨细胞切除术(LSTG)是合适的程序,如术后营养状况和手术安全性。然而,LSTG是否是上胃窦早期胃癌的肿瘤上可接受的程序尚不清楚。方法分析215例CT1N0M0胃癌患者,限制位于上胃体积。从每个预期程序转换为替代程序的频率,病理裕度的宽度,每站淋巴结转移的发病率和3年的总存活(OS)和无复发存活(RFS)。结果LSTG分别计划65名患者,分别为72例72患者78例。在计划LSTG或LPG的约10%患者中需要转换为其他程序。接受LSTG的患者的病理余量的宽度明显短于接受其他人的患者。没有在LSTG,LPG或LTG接受LSTG的患者在车站没有转移。 2或4SA淋巴结。 3年的操作系统和计划计划的患者的rfs率没有不同。结论LSTG可能是上胃体中CT1N0M0胃癌的肿大可接受的方法。 LSTG可能是这种疾病的一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号